Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Los términos de búsqueda han de ser en inglés.

A Korean biotech company is looking for innovative biological technologies in early research stage with mechanism of action (MOA) and efficacy test results to perform further development of non-clinical studies and clinical trials for commercialization

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRKR20210805001
Publicado:
12/11/2021
Caducidad:
13/11/2022
Resumen:
A Korean company has proven experience in the development of biopharmaceutical products based on technology transfer from a foreign company. The company is looking for companies, research institutions, or universities in EU countries that have innovative technologies targeting mitochondria metabolism, autophagy, or micropinocytosis in KRAS (Kirsten RAt Sarcoma) mutant or wild-type cancer cells under a license agreement or a research cooperation agreement.

Details

Tittle:
A Korean biotech company is looking for innovative biological technologies in early research stage with mechanism of action (MOA) and efficacy test results to perform further development of non-clinical studies and clinical trials for commercialization
Summary:
A Korean company has proven experience in the development of biopharmaceutical products based on technology transfer from a foreign company. The company is looking for companies, research institutions, or universities in EU countries that have innovative technologies targeting mitochondria metabolism, autophagy, or micropinocytosis in KRAS (Kirsten RAt Sarcoma) mutant or wild-type cancer cells under a license agreement or a research cooperation agreement.
Description:
The Korean company is looking for innovative technologies targeting mitochondria metabolism, autophagy, or micropinocytosis in KRAS* mutant or wild-type cancer cells.

The company has long-standing experts with extensive experience for more than 30 years so that drug development and commercialization can be implemented without difficulty. The team´s core competency is the ability to perform at a high-quality level in specific consulting projects for decades such as IND (Investigational New Drug), clinical trials, marketing approvals in home and abroad, protein/antibody therapeutics, cell/gene therapy, vaccines, etc.

One area of mediate interest is the high basal autophagic flux and autophagosome-lysosome fusion pathway under the hypoxic and/or nutrients-depleted environment of cancer cells. Autophagy defect often results in cancer cell death due to lysosome inhibition to impair autophagosome-lysosome fusion.

The company wants to in-license the technology and/or material for further development and commercialization under a license agreement. As for inflammation diseases, the company is looking for a partner(s) to do joint research with provided test materials provided under a research cooperation. Target diseases are open to discussion, but the company prefers a specific area with lots of research papers and data of partners´.

The company intends to perform further development of non-clinical studies and clinical trials for commercialization after the technology transfer from the European entities.

*KRAS operates an ´on-off system´ that regulates GDP( Guanosine diphosphate)deactivation or GTP(Guanosine-5´-triphosphate) activation. This signals cell growth by alternating between GTP active and GDP inactive.
Technical Specification or Expertise Sought:
Technical Specification Sought: Partners are expected to help develop products for inflammation diseases and cancers without chemicals. Peptides, proteins, or antibodies are acceptable. The manufacturing process and productivity do not matter.

Partner sought

Type and Role of Partner Sought:
The company is seeking partners to in-license the technology and/or material for further development and commercialization under a license agreement. They would like to perform further development of non-clinical studies and clinical trials for commercialization after the technology transfer from the European entities.

As for inflammation diseases, the company also is looking for a partner(s) to do joint research with provided test materials for adaptation to a new field or application of a technology, product or process under a research cooperation.

Biotech companies, research institutes, or universities with innovative technologies for biological products to treat human can be the types of partner sought diseases.

Client

Type and Size of Client:
Industry SME 11-49
Already Engaged in Trans-National Cooperation:
No
Languages Spoken:
English